Here are a few of the most interesting Astellas statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
- Website: Official Website
- Year Founded: 2005
- Headquarters: Tokyo, Japan
- Founder(s): Tomokichi Fujisawa
- Current Chief Executive: Kenji Yasukawa
What is Astellas?
Astellas Pharma Inc., is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. (source)
Astellas Employee Count
Astellas number of employees:
Last updated 3/1/20
Astellas Revenue Totals
Astellas annual revenue:
- FY 2019: 1,300,843 million yen
- FY 2018: 1,306,348 million yen
- FY 2017: 1,300,316 million yen
- FY 2016: 1,311,665 million yen
- FY 2015: 1,372,706 million yen
Astellas annual gross profit:
- FY 2019: 1,024,104 million yen
- FY 2018: 1,014,299 million yen
- FY 2017: 1,006,066 million yen
- FY 2016: 991,162 million yen
- FY 2015: 1,037,110 million yen
Get the Full Industry Report
This full report is available in an annual industry report. Some of the data in industry reports include:
- Company Quick Facts
- Employee Counts
- Income and Revenue Totals
- Etc.- all in one place
I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed.
To get your copy of the report, click on the button below to purchase it.
Report 1: Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).